DIA
Drug Information Association Logo

Development of an ELISA Method to Characterize C1q Binding Affinity

Time

Tue, Jun 17 7:15AM
T 08

Title

Development of an ELISA Method to Characterize C1q Binding Affinity

Abstract Summary

We have developed an in vitro immunoassay that characterizes the C1q binding potential of human IgG. The development involved optimizing the ELISA assay procedure and conducting statistical analysis of the data in order to determine if the assay could compare relative C1q binding affinities.

Poster Presenter

Kelly S Colletti
PhD, MBA,
Research Scientist,
Charles River Laboratories International, Inc.
United States